Altimmune (NASDAQ:ALT) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Altimmune (NASDAQ:ALT – Free Report) from a sell rating to a hold rating in a research note released on Thursday. A number of other equities analysts have also commented on ALT. HC Wainwright reiterated a “buy” rating and set a $12.00 price target on shares of Altimmune in a […]
Wall Street Zen upgraded shares of Altimmune (NASDAQ:ALT – Free Report) from a sell rating to a hold rating in a research note released on Thursday. A number of other equities analysts have also commented on ALT. HC Wainwright reiterated a “buy” rating and set a $12.00 price target on shares of Altimmune in a […]
